Welcome to the 6th Microbiome Movement - Drug Development Summit

The most comprehensive forum for microbiome drug developers, the Microbiome Movement – Drug Development Summit returns for its sixth iteration!

Continuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, advance clinical development, overcome the key CMC challenges, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes, this is the must attend conference for microbiome drug developers.

Recent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic, however, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease, and translate the complex science into realized and effective therapies that improve patient outcomes.

Our end-to-end discussion will unite 65+ expert speakers, and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress, overcome obstacles to therapeutic approval and provide unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality.

The 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap, discover the next generation of microbiome-based therapeutics, and establish new partnerships to accelerate your research.

Our 65+ World Class Speakers Include

Bernat Olle

Bernat Olle


Vedanta Biosciences

Gokul Swaminathan

Associate Principal Scientist, Investigational Biology

Merck Exploratory Science

Ken Blount

Ken Blount



Matthew Henn

Executive VP & CSO

Seres Therapeutics

Stephanie Culler

Co-Founder & CEO

Persephone Biosciences

Emily Drabant Conley


Federation Bio

Mark Smith

Mark Smith


Finch Therapeutics

Nikole Kimes


Siolta Therapeutics

Paul Carlson

Principal Investigator


Scott Plevy


Senda Biosciences

4 Areas that Define the Drug Development Summit

Understanding Microbiome Function & Pre-Clinical Development

Learn the approaches and platforms being harnessed to identify new therapeutic targets to see how you can incorporate the latest scientific findings into your own product pipeline


Clinical Translation & Manufacturing of Microbiome Therapeutics

Hear from subject experts on the major challenges of translating microbiome products through the clinic in order to learn how you can move your products closer to approval and commercialization

Microbiome Biomarkers, Patient Stratification & Diagnostics 

Mine the human microbiome to discover new biomarkers and uncover how biomarkers are being used in clinical development in order to better stratify patients and improve clinical outcomes

Pre-Conference Immune-Disease Focus Day

Explore the latest science understanding the causal role of the microbiome in the development of immune-based diseases, to better inform development of candidates focused on IBD and immune-oncology

Hear What the Microbiome Community Says

"The Microbiome Movement – Drug Development Summit is the premier meeting in the microbiome field, and a “must-attend” for those involved in microbiome related drug development”

Blake Wise, Novome Biotechnologies

"This summit offers great opportunity for researchers to share findings and advancements in the microbiome field, and greatly fosters the development of microbiome-based therapeutics and diagnostis

Xue Liang, Merck Exploratory Science

Confirmed Partners for 2021 Include

Industry Partner:

Microbiotica logo 2

Lead Partner:

Boston Analytical

Expertise Partners:

ArrantaBio_Logo_CMYK (002)

Other Confirmed Partners:

logo 1500x1500px v2
polardry_logo_wtag 110419
Human Metabolome Technologies - Innovation Partner

Other Events In The Series